Streetbeat News

Products Services

DE

Deere & Company forecasts a net income of $7 billion for fiscal year 2024. The company is taking steps to reduce costs and align production with customer needs in response to weak market conditions. These measures are aimed at maintaining competitiveness and continuing investment in innovative products.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:15 am

AIRE

reAlpha Tech has launched reAlpha AI Labs, a research and development initiative aimed at developing, partnering with, and potentially investing in AI startups. This initiative will support early-stage companies and enhance reAlpha's generative AI-powered home buying platform, Claire.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:12 am

SIX

Six Flags announced significant investments for 2025, including seven new roller coasters, expanded seasonal events, and new food and beverage offerings. The company also introduced an All Park Passport Add-On for unlimited admission and parking across all its parks.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:01 am

GOOG

GOOGL

Former Google CEO Eric Schmidt retracted his comments blaming Google's focus on work-life balance and remote work for its competitive disadvantage against AI startups like OpenAI. Schmidt acknowledged his error in an email to The Wall Street Journal. The debate on remote work's impact on productivity remains unresolved, with mixed research findings.

Portfolio Pulse from Rounak Jain

August 15, 2024 | 9:54 am

WENA

ANEW Medical, Inc. (NASDAQ:WENA) has secured a U.S. patent for its Klotho gene therapy targeting neurodegenerative diseases. This patent strengthens ANEW's IP portfolio, which includes exclusive worldwide rights to develop and commercialize treatments for conditions like Alzheimer's, ALS, and Parkinson's disease.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 9:03 am

AZN

The FDA has accepted AstraZeneca's supplemental biologics license application for Imfinzi (Durvalumab) under priority review for limited-stage small cell lung cancer. The Prescription Drug User Fee Act date is anticipated during the fourth quarter of 2024.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 8:55 am

ALVO

The European Medicines Agency (EMA) has accepted Alvotech and Advanz Pharma's Marketing Authorization Application for AVT06, a biosimilar to Eylea. The authorization process could be completed by Q3 2025.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 8:32 am

WZZZY

Wizz Air (OTC:WZZZY) has introduced a $550 annual pass for unlimited flights to attract customers amid declining profits and customer satisfaction. The pass will increase to 599 euros after Friday and includes additional fees for bookings and luggage. This move follows similar initiatives by U.S. carriers like Frontier Airlines.

Portfolio Pulse from Benzinga Neuro

August 15, 2024 | 8:29 am

BA

Boeing (NYSE:BA) has secured a significant deal with EL AL Israel Airlines for up to 31 737 MAX jets, aiding the airline's fleet renewal plans.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 8:13 am

INTC

NVDA

TSM

SoftBank's plans to produce an AI chip to rival Nvidia have hit a roadblock as talks with Intel fell through. SoftBank is now looking to Taiwan Semiconductor Manufacturing Co. for production. This shift comes amid Intel's cost-cutting measures and layoffs.

Portfolio Pulse from Benzinga Neuro

August 15, 2024 | 7:29 am